Regorafenib (Stivarga) Should Be Taken With a Low-Fat Meal
Regorafenib should be taken with a low-fat meal that contains less than 30% fat to optimize absorption and efficacy. 1
Evidence-Based Rationale
The FDA label for Stivarga (regorafenib) provides clear guidance on administration with food:
- In the pivotal clinical trials (CORRECT and GRID) that led to FDA approval, regorafenib was administered with a low-fat breakfast 1
- Pharmacokinetic studies show that food significantly affects regorafenib absorption:
Administration Guidelines
Recommended Approach
- Take the standard dose of 160mg (four 40mg tablets) once daily with a low-fat breakfast
- Continue for the first 21 days of each 28-day cycle
- Maintain consistent timing of administration relative to meals
What Constitutes a Low-Fat Meal
A low-fat meal should contain:
- Approximately 300-320 calories
- Less than 30% of calories from fat (approximately 8-10g of fat)
- Examples: toast with jam, fruit, and skim milk; cereal with low-fat milk and fruit
Clinical Implications
Taking regorafenib with food has important implications for:
Efficacy: The clinical trials that demonstrated survival benefit used administration with a low-fat meal 1
Bioavailability: Food increases the absorption of both the parent drug and its active metabolites, which is essential for therapeutic effect 1
Consistency: Taking the medication consistently with similar meals helps maintain stable drug levels
Managing Side Effects
Regorafenib has significant side effects that require careful management:
- Common adverse events include hand-foot skin reaction, diarrhea, hypertension, and fatigue 2
- Taking with food may help mitigate some gastrointestinal side effects, though this must be balanced with the specific food requirements
- In clinical trials, dose interruptions and reductions were required in 58% and 50% of patients, respectively 2
Important Considerations
- Avoid high-fat meals: A high-fat meal (945 calories, 54.6g fat) alters the metabolite profile differently than a low-fat meal, decreasing some active metabolites 1
- Maintain consistency: Take at approximately the same time each day with similar food content
- Adherence is critical: The GEIS guidelines emphasize that checking adherence to treatment is the first recommended measure when evaluating treatment failure 2
Common Pitfalls to Avoid
- Taking on an empty stomach, which reduces bioavailability
- Taking with a high-fat meal, which alters the metabolite profile
- Inconsistent timing or food content, which may lead to variable drug levels
- Discontinuing due to side effects rather than discussing dose modifications with healthcare providers
Following these evidence-based recommendations for taking regorafenib with a low-fat meal will help optimize treatment outcomes while managing side effects appropriately.